• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Improving pandemic influenza risk assessment

tetano

Editor, Senior Moderator
Elife. 2014 Oct 16;3. doi: 10.7554/eLife.03883.
Improving pandemic influenza risk assessment.
Russell CA1, Kasson PM2, Donis RO3, Riley S4, Dunbar J5, Rambaut A6, Asher J7, Burke S8, Davis CT9, Garten RJ10, Gnanakaran S11, Hay SI12, Herfst S13, Lewis NS14, Lloyd-Smith JO15, Macken CA16, Maurer-Stroh S17, Neuhaus E18, Parrish CR19, Pepin KM20, Shepard SS21, Smith DL22, Suarez DL23, Trock SC24, Widdowson MA25, George DB26, Lipsitch M27, Bloom JD28.
Author information
Abstract

Assessing the pandemic risk posed by specific non-human influenza A viruses is an important goal in public health research. As influenza virus genome sequencing becomes cheaper, faster, and more readily available, the ability to predict pandemic potential from sequence data could transform pandemic influenza risk assessment capabilities. However, the complexities of the relationships between virus genotype and phenotype make such predictions extremely difficult. The integration of experimental work, computational tool development, and analysis of evolutionary pathways, together with refinements to influenza surveillance, has the potential to transform our ability to assess the risks posed to humans by non-human influenza viruses and lead to improved pandemic preparedness and response.
KEYWORDS:

emergence; evolutionary biology; genomics; human; infectious disease; influenza; microbiology; pandemic; viruses

http://www.ncbi.nlm.nih.gov/pubmed/25321142
 
Back
Top Bottom